KÖROĞLU, R. Et Al. 2015. Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging. International Journal of Nuclear Medicine Research , vol.2 , 1-6.

KÖROĞLU, R., ÖZKAN, E., SOYDAL, Ç., & İBİŞ, E., (2015). Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging. International Journal of Nuclear Medicine Research , vol.2, 1-6.

KÖROĞLU, REYHAN Et Al. "Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging," International Journal of Nuclear Medicine Research , vol.2, 1-6, 2015

KÖROĞLU, REYHAN Et Al. "Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging." International Journal of Nuclear Medicine Research , vol.2, pp.1-6, 2015

KÖROĞLU, R. Et Al. (2015) . "Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging." International Journal of Nuclear Medicine Research , vol.2, pp.1-6.

@article{article, author={REYHAN KÖROĞLU Et Al. }, title={Fluorine 18 Fluorodeoxyglucose positron emission tomography computed tomography in the detection of ovarian cancer recurrence in patients with elevated serum Ca 125 levels and whether the recurrence appears by conventional imaging}, journal={International Journal of Nuclear Medicine Research}, year=2015, pages={1-6} }